MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

November 2006


Persistence with Pharmacotherapy for Gastrointestinal Disease: Associated Costs of Health Care

A study was conducted to assess the association between health care costs and patient adherence to aminosalicylate pharmacotherapy for digestive disorders.
Fadia T. Shaya, PhD, MPH, Antoine C. El Khoury, PhD, Winston Wong, PharmD, Nevin Whitelaw, BSc, George Whitelaw, RPh, Raymond E. Joseph, MD, and Russell D. Cohen, MD

Consensus Statement on the Use of Botulinum Neurotoxin to Treat Spasticity in Adults

The Neurotoxin Spasticity Consensus Group presents its findings on botulinum toxin in the treatment of various conditions characterized by muscle overactivity.
Thomas L. Davis, MD, Matthew A. Brodsky, MD, Victoria A. Carter, MD, Marc DiFazio, MD, Ben Frishberg, MD, Eugene C. Lai, MD, PhD, John McGuire, MD, Douglas P. Meyer, RPh, Jill L. Ostrem, MD, Aliya I. Sarwar, MD, and Kevin White, MD

Meeting Highlights

World Congress of Cardiology 2006

The safety and efficacy of ACE-inhibitors (ramipril, perindopril, and trandolapril), an angiotensin-receptor blocker (valsartan), an anticoagulant/antiplatelet combination, and a direct renin inhibitor (aliskiren) are reviewed.
Reuben B. David

Meeting Highlights

46th Interscience Conference on Antimicrobial Agents and Chemotherapy

The authors report on ceftaroline for skin and skin-structure infections; cethromycin for acute bacterial exacerbations of chronic bronchitis; tigecycline for community-acquired pneumonia; ceftobiprole for skin infections; moxifloxacin for leprosy; telithromycin for acute bacterial sinusitis; oseltamivir to reduce pneumonia risk following pediatric influenza; a human papillomavirus vaccine; and micafungin for invasive candidiasis in children.
Lawrence M. Prescott, PhD, and Sharon L. Prescott

Pharmaceutical Approval Update

Three agents are discussed: posaconazole oral suspension (Noxafil) for Aspergillus and Candida infections; Travoprost Z ophthalmic solution (Travatan Z), for glaucoma or ocular hypertension; and arformoterol tartrate inhalation solution (Brovana) for obstructive pulmonary disease, chronic bronchitis, and emphysema.
Marvin M. Goldenberg, PhD, RPh, MS



Ready for Registries?

David Nash, MD, MBA, discusses the advantages of electronic medical records and the forthcoming development of linked registries that hold promise for improving outcomes for patients with chronic disease.
David Nash, MD, MBA

Medication Errors

ISMP Survey Results: Pharmacy Interventions Can Reduce Clinical Errors

Matthew Grissinger, RPh, FASCP, reports on the results of a survey about the role of appropriate interventions for preventing clinical errors.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

A First Step Toward Measuring Pharmacy Performance: Will the Pharmacy Quality Alliance Lead the Way?

Stephen Barlas discusses the Pharmacy Quality Alliance, a collaboration to develop new strategies for measuring pharmacy performance, with the goal of improving patient outcomes.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

Anidulafungin (Eraxis) for Fungal Infections

The authors review anidulafungin (Eraxis) for the treatment of fungal infections.
Priti N. Patel, PharmD, BCPS, and Lisa Charneski, PharmD, BCPS